These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 25901093)

  • 1. Rate of change in renal function and mortality in elderly treated hypertensive patients.
    Chowdhury EK; Langham RG; Ademi Z; Owen A; Krum H; Wing LM; Nelson MR; Reid CM;
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1154-61. PubMed ID: 25901093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in the estimated glomerular filtration rate over time and risk of all-cause mortality.
    Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
    Kidney Int; 2013 Apr; 83(4):684-91. PubMed ID: 23344477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial.
    Peters R; Beckett N; Poulter R; Burch L; Narkiewicz K; Fagard R; Nitsch D; Wang N; Li M; Fletcher A; Bulpitt C
    Age Ageing; 2013 Mar; 42(2):253-8. PubMed ID: 22910302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of predictive performance of renal function estimation equations for all-cause and cardiovascular mortality in an elderly hypertensive population.
    Chowdhury EK; Langham RG; Owen A; Krum H; Wing LM; Nelson MR; Reid CM;
    Am J Hypertens; 2015 Mar; 28(3):380-6. PubMed ID: 25239479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio of blood urea nitrogen to serum creatinine at initiation of dialysis is associated with mortality: a multicenter prospective cohort study.
    Inaguma D; Koide S; Ito E; Takahashi K; Hayashi H; Hasegawa M; Yuzawa Y;
    Clin Exp Nephrol; 2018 Apr; 22(2):353-364. PubMed ID: 28766029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.
    Whittle J; Lynch AI; Tanner RM; Simpson LM; Davis BR; Rahman M; Whelton PK; Oparil S; Muntner P
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):471-80. PubMed ID: 26912544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hyperuricemia on the blood pressure response to antihypertensive agents in hospitalized elderly patients.
    Zhu P; Lin F; Lin C; Hong D; Lin K; Chen H
    J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):741-6. PubMed ID: 22964647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of BP with Death, Cardiovascular Events, and Progression to Chronic Dialysis in Patients with Advanced Kidney Disease.
    Palit S; Chonchol M; Cheung AK; Kaufman J; Smits G; Kendrick J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):934-40. PubMed ID: 25979975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function and decline in functional capacity in older adults.
    Chin HJ; Ahn SY; Ryu J; Kim S; Na KY; Kim KW; Chae DW; Kim CH; Kim KI
    Age Ageing; 2014 Nov; 43(6):833-8. PubMed ID: 24908107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.
    Rebholz CM; Grams ME; Matsushita K; Inker LA; Foster MC; Levey AS; Selvin E; Coresh J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):941-8. PubMed ID: 25825481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease.
    Okada T; Nakao T; Matsumoto H; Nagaoka Y; Tomaru R; Iwasawa H; Wada T
    Hypertens Res; 2009 Dec; 32(12):1123-9. PubMed ID: 19816503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria:
    Chang AR; Kramer H; Wei G; Boucher R; Grams ME; Berlowitz D; Bhatt U; Cohen DL; Drawz P; Punzi H; Freedman BI; Haley W; Hawfield A; Horwitz E; McLouth C; Morisky D; Papademetriou V; Rocco MV; Wall B; Weiner DE; Zias A; Beddhu S;
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1121-1128. PubMed ID: 32669306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between renal function and cardiovascular and all-cause mortality in the community-based elderly population: results from the Specific Health Check and Guidance Program in Japan.
    Kon S; Konta T; Ichikawa K; Asahi K; Yamagata K; Fujimoto S; Tsuruya K; Narita I; Kasahara M; Shibagaki Y; Iseki K; Moriyama T; Kondo M; Watanabe T
    Clin Exp Nephrol; 2018 Apr; 22(2):346-352. PubMed ID: 28744566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased systolic blood pressure is associated with increased risk of all-cause mortality in patients with type 2 diabetes and renal impairment: A nationwide longitudinal observational study of 27,732 patients based on the Swedish National Diabetes Register.
    Svensson MK; Afghahi H; Franzen S; Björk S; Gudbjörnsdottir S; Svensson AM; Eliasson B
    Diab Vasc Dis Res; 2017 May; 14(3):226-235. PubMed ID: 28467201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term survival in treated elderly hypertensive patients with or without diabetes: findings from the Second Australian National Blood Pressure study.
    Chowdhury EK; Owen A; Ademi Z; Krum H; Johnston CI; Wing LM; Nelson MR; Reid CM;
    Am J Hypertens; 2014 Feb; 27(2):199-206. PubMed ID: 24249722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients.
    Perticone F; Maio R; Perticone M; Sciacqua A; Shehaj E; Naccarato P; Sesti G
    Circulation; 2010 Jul; 122(4):379-84. PubMed ID: 20625109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
    Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
    Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease.
    Mallamaci F; Minutolo R; Leonardis D; D'Arrigo G; Tripepi G; Rapisarda F; Cicchetti T; Maimone I; Enia G; Postorino M; Santoro D; Fuiano G; De Nicola L; Conte G; Zoccali C
    Kidney Int; 2013 Aug; 84(2):381-9. PubMed ID: 23615498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population.
    Guessous I; McClellan W; Kleinbaum D; Vaccarino V; Hugues H; Boulat O; Marques-Vidal P; Paccaud F; Theler JM; Gaspoz JM; Burnier M; Waeber G; Vollenweider P; Bochud M
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1162-9. PubMed ID: 25901090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.